Difference between calculated and direct-measured low-density lipoprotein cholesterol in subjects with diabetes mellitus or taking lipid-lowering medications

被引:14
|
作者
Choi, Su-Yeon [2 ]
Park, Hyo Eun [2 ]
Kim, Min-Kyung [2 ]
Shin, Chan Soo [2 ]
Cho, Sang-Heon [2 ]
Oh, Byung-Hee [1 ]
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul 135984, South Korea
关键词
Low-density lipoprotein cholesterol; Friedewald formula; Diabetes mellitus; Triglyceride; Community-based study; CORONARY-HEART-DISEASE; ASSAY; RISK;
D O I
10.1016/j.jacl.2011.12.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: We evaluated factors that caused differences between calculated low-density lipoprotein cholesterol (C-LDL-C) and direct-measured LDL-C (D-LDL-C) and compared them in subjects with diabetes mellitus (DM) or taking lipid-lowering medications. METHODS: 21,452 subjects (9,177 women, 12,275 men; 8.1% with DM and 8.5% on lipid-lowering medications) were included in the analysis. Participants were classified into 3 groups, i.e., group 1: the subjects without DM and not on lipid-modifying drugs (n = 18,287), group 2: without DM and on lipid-modifying drugs (n = 1,423), and group 3: with DM (n = 1,742). LDL-C concentrations were either directly measured by a homogenous method or calculated by Friedewald formula. RESULTS: There was a significant correlation between C-LDL-C and D-LDL-C (r = 0.966, P < .001). The absolute values of the differences between two LDL-C values were 7.0 +/- 6.2 mg/dl and 6.6 +/- 7.3% (6.6 +/- 5.9 mg/dl and 6.0 +/- 6.5%, 8.8 +/- 6.7 mg/dl and 9.1 +/- 9.7%, and 10.1 +/- 7.3 mg/dl and 10.7 +/- 10.1% in group 1, 2, and 3 respectively, P < .001). The subjects with the absolute value of the differences of LDL-C >= 10% was 20.2% (17.3%, 31.3%, and 41.1% in group 1, 2, and 3 respectively, P < .001). In the multiple logistic regression analysis, high triglyceride (>= 150 mg/dl), low high-density lipoprotein cholesterol (HDL-C) (<40 mg/dl), male gender, obesity (body mass index >= 25 kg/m(2)), DM and taking lipid-lowering drugs were significant associated with high LDL-differences (the absolute value of the differences >= 10% or >= 10 mg/dl). CONCLUSION: D-LDL-C was generally higher by 5 mg/dl or 5% than C-LDL-C. The differences C-LDL-C and D-LDL-C were higher in subjects with DM and on lipid-lowering medications. Male gender, high triglyceride, low HDL-C, and obesity were also associated with the greater differences between C-LDL-C and D-LDL-C. (C) 2012 National Lipid Association. All rights reserved.
引用
收藏
页码:114 / 120
页数:7
相关论文
共 50 条
  • [31] Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome
    Wang, Qinqin
    Liang, Chun
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (06) : 658 - 670
  • [32] Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect
    Cairoli, E.
    Rebella, M.
    Danese, N.
    Garra, V.
    Borba, E. F.
    LUPUS, 2012, 21 (11) : 1178 - 1182
  • [33] Association between low-density lipoprotein cholesterol and sudden cardiac arrest in people with diabetes mellitus
    Yun Gi Kim
    Joo Hee Jeong
    Kyung-Do Han
    Seung-Young Roh
    Kyongjin Min
    Hyoung Seok Lee
    Yun Young Choi
    Jaemin Shim
    Jong-Il Choi
    Young-Hoon Kim
    Cardiovascular Diabetology, 22
  • [34] Association between low-density lipoprotein cholesterol and sudden cardiac arrest in people with diabetes mellitus
    Kim, Yun Gi
    Jeong, Joo Hee
    Han, Kyung-Do
    Roh, Seung-Young
    Min, Kyongjin
    Lee, Hyoung Seok
    Choi, Yun Young
    Shim, Jaemin
    Choi, Jong-Il
    Kim, Young-Hoon
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [35] Pro and con: Low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid management
    Pedersen, TR
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (5A): : 8B - 12B
  • [36] A clinical comparison of calculated versus direct measurement of low-density lipoprotein cholesterol level
    Lindsey, CC
    Graham, MR
    Johnston, TR
    Kiroff, CG
    Freshley, A
    PHARMACOTHERAPY, 2004, 24 (02): : 167 - 172
  • [37] Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
    Yan, Xiaowei
    Li, Yong
    Dong, Yugang
    Wu, Yanhua
    Li, Jihu
    Bian, Rui
    Hu, Dayi
    LIPIDS IN HEALTH AND DISEASE, 2019, 18 (1)
  • [38] Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
    Xiaowei Yan
    Yong Li
    Yugang Dong
    Yanhua Wu
    Jihu Li
    Rui Bian
    Dayi Hu
    Lipids in Health and Disease, 18
  • [39] Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease
    Mendelson, G
    Aronow, WS
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) : 1128 - 1131
  • [40] Comparison of calculated and directly measured low-density lipoprotein cholesterol in patients with acute myocardial infarction
    Lee, J. H.
    Chae, S. C.
    Jeong, M. H.
    Kim, Y. J.
    Kim, K. S.
    Hur, S. H.
    Seong, I. W.
    Hong, T. J.
    Cho, M. C.
    Kim, C. J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 958 - 959